Literature DB >> 12727936

Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.

Richard J Robbins1, Anne K Robbins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12727936     DOI： 10.1210/jc.2002-021979

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.

Authors:  Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Mihriye Mete; Jacqueline Jonklaas; Leonard Wartofsky
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

2.  A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.

Authors:  M Giusti; F Sibilla; C Cappi; M Dellepiane; F Tombesi; E Ceresola; C Augeri; E Rasore; F Minuto
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

3.  Recombinant human thyrotropin use resulting in ovarian hyperstimulation: an unusual side effect.

Authors:  Tanvir Rizvi; Patrice K Rehm
Journal:  Eur Thyroid J       Date:  2014-06-07

4.  Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.

Authors:  C Regalbuto; C Alagona; R Maiorana; R Di Paola; M Cianci; G Alagona; S Sapienza; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

5.  Rational management of differentiated thyroid cancer.

Authors:  Birendra Kishore Das; Biswa Mohan Biswal; Venkata Murali Krishna Bhavaraju
Journal:  Malays J Med Sci       Date:  2006-07

Review 6.  Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Mihriye Mete; Jacqueline Jonklaas; Leonard Wartofsky
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.